(Q46586294)

23 December 2017

title

Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma (English)

1 reference

23 December 2017

1 reference

1 reference

1

1 reference

23 December 2017

Patrizia Agostinis

7

1 reference

23 December 2017

Lien Vandenberk

2

Lien Vandenberk

1 reference

23 December 2017

Stefaan Van Gool

6

Stefaan W Van Gool

1 reference

23 December 2017

Louis Boon

5

Louis Boon

1 reference

23 December 2017

Tina Verschuere

4

Tina Verschuere

1 reference

23 December 2017

Carolien A M Koks

3

Carolien Koks

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 March 2016

1 reference

23 December 2017

Science Translational Medicine

published in

1 reference

23 December 2017

volume

8

1 reference

23 December 2017

issue

328

1 reference

23 December 2017

page(s)

328ra27

1 reference

23 December 2017

Dendritic-cell-based therapeutic cancer vaccines

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Clinical use of dendritic cells for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Active dendritic cell immunotherapy for glioblastoma: Current status and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Targeting adaptive glioblastoma: an overview of proliferation and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Dendritic cell therapy of high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Immunogenic cell death in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Danger signalling during cancer cell death: origins, plasticity and regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Immunocompetent murine models for the study of glioblastoma immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

MyD88: a critical adaptor protein in innate immunity signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Impact of temozolomide on immune response during malignant glioma chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

The prognostic landscape of genes and infiltrating immune cells across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

The somatic genomic landscape of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Hypericin for visualization of high grade gliomas: first clinical experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Impact of tumour volume on the potential efficacy of therapeutic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

The Cancer Genome Atlas Pan-Cancer analysis project

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Open source clustering software

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Java Treeview--extensible visualization of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

PROGgeneV2: enhancements on the existing database

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Epigenetic biomarkers of T-cells in human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Regulatory T cells are not a strong predictor of survival for patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Prognostic value of the preoperative immunological profile in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Tumour-infiltrating T-cell subpopulations in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Prognostic significance and mechanism of Treg infiltration in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for gliblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAE0105

10.1126/SCITRANSLMED.AAE0105

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

26936504

1 reference

23 December 2017